These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22256443)

  • 1. The impact of MRSA infection in the airways of children with cystic fibrosis; a case-control study.
    Cox DW; Kelly C; Rush R; O'Sullivan N; Canny G; Linnane B
    Ir Med J; 2011; 104(10):305-8. PubMed ID: 22256443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function.
    Ren CL; Morgan WJ; Konstan MW; Schechter MS; Wagener JS; Fisher KA; Regelmann WE;
    Pediatr Pulmonol; 2007 Jun; 42(6):513-8. PubMed ID: 17469151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis.
    Dasenbrook EC; Merlo CA; Diener-West M; Lechtzin N; Boyle MP
    Am J Respir Crit Care Med; 2008 Oct; 178(8):814-21. PubMed ID: 18669817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and impact on FEV(1) decline of chronic methicillin-resistant Staphylococcus aureus (MRSA) colonization in patients with cystic fibrosis. A single-center, case control study of 165 patients.
    Vanderhelst E; De Meirleir L; Verbanck S; Piérard D; Vincken W; Malfroot A
    J Cyst Fibros; 2012 Jan; 11(1):2-7. PubMed ID: 21907637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis.
    Hubert D; Réglier-Poupet H; Sermet-Gaudelus I; Ferroni A; Le Bourgeois M; Burgel PR; Serreau R; Dusser D; Poyart C; Coste J
    J Cyst Fibros; 2013 Sep; 12(5):497-503. PubMed ID: 23291443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by patients with cystic fibrosis.
    Nadesalingam K; Conway SP; Denton M
    J Cyst Fibros; 2005 Mar; 4(1):49-52. PubMed ID: 15752681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review: Staphylococcus aureus and MRSA in cystic fibrosis.
    Goss CH; Muhlebach MS
    J Cyst Fibros; 2011 Sep; 10(5):298-306. PubMed ID: 21719362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: An eradication protocol.
    Solís A; Brown D; Hughes J; Van Saene HK; Heaf DP
    Pediatr Pulmonol; 2003 Sep; 36(3):189-95. PubMed ID: 12910579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis].
    Girón RM; Buendía B; Pinedo C; Casanova A; Hoyos N; Ancochea J
    Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):85-8. PubMed ID: 19254640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of 11 patients.
    Vanderhelst E; De Wachter E; Willekens J; Piérard D; Vincken W; Malfroot A
    J Cyst Fibros; 2013 Dec; 12(6):662-6. PubMed ID: 23706641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients.
    Vergison A; Denis O; Deplano A; Casimir G; Claeys G; DeBaets F; DeBoeck K; Douat N; Franckx H; Gigi J; Ieven M; Knoop C; Lebeque P; Lebrun F; Malfroot A; Paucquay F; Pierard D; Van Eldere J; Struelens MJ
    J Antimicrob Chemother; 2007 May; 59(5):893-9. PubMed ID: 17341469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient segregation and aggressive antibiotic eradication therapy can control methicillin-resistant Staphylococcus aureus at large cystic fibrosis centres.
    Doe SJ; McSorley A; Isalska B; Kearns AM; Bright-Thomas R; Brennan AL; Webb AK; Jones AM
    J Cyst Fibros; 2010 Mar; 9(2):104-9. PubMed ID: 20051329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.
    Jennings MT; Dasenbrook EC; Lechtzin N; Boyle MP; Merlo CA
    J Cyst Fibros; 2017 Nov; 16(6):681-686. PubMed ID: 28446387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis.
    Sawicki GS; Rasouliyan L; Pasta DJ; Regelmann WE; Wagener JS; Waltz DA; Ren CL
    Pediatr Pulmonol; 2008 Nov; 43(11):1117-1123. PubMed ID: 18846559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus (MRSA) isolation in adults with cystic fibrosis and chronic MRSA infection.
    Garske LA; Kidd TJ; Gan R; Bunting JP; Franks CA; Coulter C; Masel PJ; Bell SC
    J Hosp Infect; 2004 Mar; 56(3):208-14. PubMed ID: 15003669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment intensity and characteristics of MRSA infection in CF.
    Muhlebach MS; Miller M; LaVange LM; Mayhew G; Goodrich JS; Miller MB
    J Cyst Fibros; 2011 May; 10(3):201-6. PubMed ID: 21420912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation.
    Molina A; Del Campo R; Máiz L; Morosini MI; Lamas A; Baquero F; Cantón R
    J Antimicrob Chemother; 2008 Nov; 62(5):961-7. PubMed ID: 18647744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of nosocomial isolates of Staphylococcus aureus with special reference to methicillin resistant S. aureus in a tertiary care hospital in Nepal.
    Shrestha B; Pokhrel B; Mohapatra T
    Nepal Med Coll J; 2009 Jun; 11(2):123-6. PubMed ID: 19968154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of methicillin-resistant Staphylococcus aureus colonisation on paediatric cystic fibrosis patients' morbidity.
    Fermeiro J; Reis P; Castanhinha S; Pereira L; Barreto C
    Rev Port Pneumol; 2010; 16(4):527-42. PubMed ID: 20700553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcus aureus in the airways of cystic fibrosis patients - A retrospective long-term study.
    Schwerdt M; Neumann C; Schwartbeck B; Kampmeier S; Herzog S; Görlich D; Dübbers A; Große-Onnebrink J; Kessler C; Küster P; Schültingkemper H; Treffon J; Peters G; Kahl BC
    Int J Med Microbiol; 2018 Aug; 308(6):631-639. PubMed ID: 29501453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.